The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Puma Biotechnology, Inc(NASDAQ:PBYI) 
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the adjuvant treatment of adult patients with early st...
Website: http://www.pumabiotechnology.com
Founded: 2007
Full Time Employees: 269
Sector: Healthcare
Industry: Biotechnology
Puma Biotechnology Days Payable Outstanding ttm (DPO)
Puma Biotechnology Days Receivable Outstanding ttm (DSO)
Puma Biotechnology Days Inventory Outstanding ttm (DIO)
Puma Biotechnology Op Cashflow Per Share ttm
Puma Biotechnology Free Cashflow Per Share ttm
Puma Biotechnology Cash Per Share ttm
Puma Biotechnology P/S ratio ttm
Puma Biotechnology (GAAP) P/E ratio ttm
Puma Biotechnology P/B ratio ttm
No extra charts and metrics for this ticker.